THU-367 Prognosis of primary sclerosing cholangitis (PSC) in Hungary is independent of coexisting inflammatory bowel disease (IBD) and prognostic ability of the currently used PSC risk scores are limited

Dávid Tornai(Beth Israel Deaconess Medical Center), Mária Papp(University of Debrecen), Gabriella Pár(University of Debrecen), Zsuzsanna Vitális(Semmelweis University), István Tornai(University of Debrecen), Tamás Tornai(University of Debrecen), I Altorjay, Peter Laszlo Ven(University of Pecs)
Journal of Hepatology
May 1, 2025
10.1016/s0168-8278(25)01034-7
Cited by 0

Related Papers

Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial
|The Lancet|2022|301
MicroRNA 122, Regulated by GRLH2, Protects Livers of Mice and Patients From Ethanol-Induced Liver Disease
|Gastroenterology|2017|157
Neutrophil extracellular traps contribute to liver damage and increase defective low-density neutrophils in alcohol-associated hepatitis
|Journal of Hepatology|2022|140
IL‐1 receptor antagonist plus pentoxifylline and zinc for severe alcohol‐associated hepatitis
|Hepatology|2022|103
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial
|˜The œLancet. Gastroenterology & hepatology|2021|96